Evidence map›Paper›PMID 41301020›Full record

ArticleCancers2025

RapidPlan Knowledge-Based Radiotherapy Planning Compared to Manual Planning in Locally Advanced Non-Small-Cell Lung Cancer.

Tal Falick Michaeli, Tamar Abu Said, Stanislav Raskin, Antoni Skripai, Yakir Rottenberg, Johnathan Arnon, Philip Blumenfeld

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tal Falick MichaeliDepartment of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.ORCID 0000-0002-7733-9438
Tamar Abu SaidDepartment of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.
Stanislav RaskinDepartment of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.
Antoni SkripaiDepartment of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.ORCID 0009-0009-8581-3142
Yakir RottenbergDepartment of Medical Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.
Johnathan ArnonDepartment of Medical Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.ORCID 0000-0002-5688-5712
Philip BlumenfeldDepartment of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.ORCID 0000-0003-4672-6862

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dosimetric outcomesIMRTorgans-at-risk (OARs)RapidPlan (RP)stage III NSCLCVMAT

Identifiers

PMID41301020
PMCPMC12651467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.